MSM/7
Meeting of the Member State mechanism on substandard and falsified medical products
A/MSM/7
List of participants – Liste des Délégués
A/MSM/7/1
Provisional agenda
A/MSM/7/2
Guidance for registers of manufacturers, importers, distributors and medical products authorized by Member States
Prioritized Activity A – Develop and promote training material and guidance documents to strengthen the capacity of national/regional
regulatory authorities for the prevention and detection of and response to substandard and falsified medical products
Action: Develop recommendations regarding national registers of manufacturers, importers distributors and medical products authorized by Member States
A/MSM/7/3
Recommendations for health authorities on criteria for risk assessment and prioritization of cases of unregistered/unlicensed, substandard and falsified medical products
Activity A of the WHO Member State mechanism November 2017
A/MSM/7/4
“IDEAS”: A global communications framework to help combat the threat from substandard and falsified medical products
Outputs from the communications working group established as part of Activity E (communications) approved by the Steering Committee of the Member State mechanism in November 2015 to support the approved workplan
Lead country: United Kingdom of Great Britain and Northern Ireland
A/MSM/7/5
Discussion paper – medicines in transit
A/MSM/7/6
Report of the seventh meeting of the Member State mechanism on substandard and falsified medical products
A/MSM/7/INF./1
Working group to identify and develop appropriate strategies to understand and address the distribution or supply of substandard and falsified medical products via the internet
Terms of reference
Prioritized Activity H – Member State mechanism
